News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Danziger Asaf
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/06/2023 |
4
| Danziger Asaf (CEO) has filed a Form 4 on NovoCure Ltd|
Txns:
| Granted 367 shares
@ $35.28, valued at
$12.9k
|
|
| 01/09/2023 |
4
| Danziger Asaf (CEO) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 8,369 shares
@ $111.2338, valued at
$930.9k
Sold 2,000 shares
@ $112.8632, valued at
$225.7k
Sold 4,568 shares
@ $114.3524, valued at
$522.4k
Sold 3,702 shares
@ $115.2113, valued at
$426.5k
Sold 1,395 shares
@ $116.0618, valued at
$161.9k
Sold 999 shares
@ $117.0111, valued at
$116.9k
Sold 2,123 shares
@ $118.4714, valued at
$251.5k
Sold 1,344 shares
@ $119.3493, valued at
$160.4k
Sold 500 shares
@ $119.987, valued at
$60k
Sold 187,500 shares
@ $108, valued at
$20.3M
Granted 39 shares
@ $62.305, valued at
$2.4k
|
|
| 07/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2022 |
4
| Danziger Asaf (CEO) has filed a Form 4 on NovoCure Ltd|
Txns:
| Granted 31 shares
@ $63.818, valued at
$2k
|
|
| 11/29/2021 |
4
| Danziger Asaf (CEO) has filed a Form 4 on NovoCure Ltd|
Txns:
| Bought 3,870 shares
@ $102.36, valued at
$396.1k
Bought 1,000 shares
@ $103.37, valued at
$103.4k
Bought 104 shares
@ $96.5, valued at
$10k
|
|
| 07/08/2021 |
4
| Danziger Asaf (CEO) has filed a Form 4 on NovoCure Ltd|
Txns:
| Granted 118 shares
@ $137.122, valued at
$16.2k
|
|
| 04/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2020 |
4
| Danziger Asaf (CEO) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 21,612 shares
@ $155.24, valued at
$3.4M
Sold 24,286 shares
@ $156.091, valued at
$3.8M
Sold 24,656 shares
@ $157.037, valued at
$3.9M
Sold 9,183 shares
@ $158.094, valued at
$1.5M
Sold 4,500 shares
@ $159.323, valued at
$717k
Sold 12,092 shares
@ $160.25, valued at
$1.9M
Sold 3,500 shares
@ $160.994, valued at
$563.5k
Sold 1,426 shares
@ $162.173, valued at
$231.3k
Sold 1,300 shares
@ $162.969, valued at
$211.9k
Sold 500 shares
@ $164.109, valued at
$82.1k
Sold 700 shares
@ $165.383, valued at
$115.8k
|
|
| 09/17/2020 |
4
| Danziger Asaf (CEO) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 103,000 shares
@ $99, valued at
$10.2M
Exercised 103,000 options to buy
@ $22, valued at
$2.3M
|
|
| 07/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2020 |
4
| Danziger Asaf (CEO) has filed a Form 4 on NovoCure Ltd|
Txns:
| Granted 155 shares
@ $52.581, valued at
$8.2k
|
|
| 11/26/2019 |
4
| Danziger Asaf (CEO) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 103,000 shares
@ $95, valued at
$9.8M
Exercised 103,000 options to buy
@ $22, valued at
$2.3M
|
|
| 09/03/2019 |
4
| Danziger Asaf (CEO) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 57,913 shares
@ $90.577, valued at
$5.2M
Sold 65,768 shares
@ $91.604, valued at
$6M
Sold 500 shares
@ $92, valued at
$46k
|
|
| 07/09/2019 |
4
| Danziger Asaf (CEO) has filed a Form 4 on NovoCure Ltd|
Txns:
| Granted 471 shares
@ $27.812, valued at
$13.1k
|
|
| 07/02/2019 |
4
| Danziger Asaf (CEO) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 187,500 shares
@ $62.15, valued at
$11.7M
Exercised 187,500 options to buy
@ $7.15, valued at
$1.3M
|
|
| 06/21/2019 |
4
| Danziger Asaf (CEO) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 25,000 shares
@ $61.46, valued at
$1.5M
Exercised 25,000 options to buy
@ $11.46, valued at
$286.5k
|
|
| 06/19/2019 |
4
| Danziger Asaf (CEO) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 190,338 shares
@ $59.37, valued at
$11.3M
Exercised 190,338 options to buy
@ $14.37, valued at
$2.7M
|
|
| 06/13/2019 |
4
| Danziger Asaf (CEO) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 15,985 shares
@ $54.71, valued at
$874.5k
Sold 850 shares
@ $55.425, valued at
$47.1k
Sold 12,233 shares
@ $54.886, valued at
$671.4k
Sold 18,203 shares
@ $55.735, valued at
$1M
Exercised 16,835 options to buy
@ $14.37, valued at
$241.9k
Exercised 30,436 options to buy
@ $14.37, valued at
$437.4k
|
|
| 05/10/2019 |
4
| Danziger Asaf (CEO) has filed a Form 4 on NovoCure Ltd|
Txns:
| Granted 115,060 options to buy
@ $47.56, valued at
$5.5M
Granted 35,000 options to buy
@ $47.56, valued at
$1.7M
|
|
| 03/26/2019 |
4
| Danziger Asaf (CEO) has filed a Form 4 on NovoCure Ltd|
Txns:
| Granted 24,554 shares
@ $0
Granted 44,953 options to buy
@ $47.04, valued at
$2.1M
|
|
| 03/06/2019 |
4
| Danziger Asaf (CEO) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 3,700 shares
@ $54.64, valued at
$202.2k
Sold 6,127 shares
@ $56.002, valued at
$343.1k
Sold 6,441 shares
@ $56.512, valued at
$364k
Exercised 16,268 options to buy
@ $14.37, valued at
$233.8k
|
|
| 03/04/2019 |
4
| Danziger Asaf (CEO) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 37,282 shares
@ $54.973, valued at
$2M
Sold 55,815 shares
@ $55.848, valued at
$3.1M
Sold 6,903 shares
@ $56.486, valued at
$389.9k
Exercised 100,000 options to buy
@ $14.37, valued at
$1.4M
|
|
| 03/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/25/2019 |
4
| Danziger Asaf (CEO) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 88,695 shares
@ $47.48, valued at
$4.2M
Exercised 88,695 options to buy
@ $7.48, valued at
$663.4k
|
|
| 01/22/2019 |
4
| Danziger Asaf (CEO) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 33,219 shares
@ $45.804, valued at
$1.5M
Sold 13,644 shares
@ $46.159, valued at
$629.8k
Exercised 46,863 options to buy
@ $3.44, valued at
$161.2k
|
|
| 01/18/2019 |
4
| Danziger Asaf (CEO) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 98,213 shares
@ $45.049, valued at
$4.4M
Sold 1,787 shares
@ $45.275, valued at
$80.9k
Sold 100,000 shares
@ $45.264, valued at
$4.5M
Exercised 100,000 options to buy
@ $3.44, valued at
$344k
Exercised 100,000 options to buy
@ $3.44, valued at
$344k
|
|
| 01/16/2019 |
4
| Danziger Asaf (CEO) has filed a Form 4 on NovoCure Ltd|
Txns:
| Sold 100,000 shares
@ $43.524, valued at
$4.4M
Sold 100,000 shares
@ $43.488, valued at
$4.3M
Exercised 100,000 options to buy
@ $3.44, valued at
$344k
Exercised 100,000 options to buy
@ $3.44, valued at
$344k
|
|
|
|
|